CASE REPORT
Year : 2022 | Volume
: 14 | Issue : 2 | Page : 60--61
Treatment of resistant alopecia areata with tofacitinib
Ganesh Avhad
Skin and Hair World, Mumbai, Maharashtra, India
Correspondence Address:
Ganesh Avhad
Skin and Hair World, M3, Shivam Building, Above Wellness Forever Chemist, Opp. PVR Cinema, Sion Circle, Mumbai - 400 022, Maharashtra
India
The activity of tofacitinib for Alopecia areata (AA) has been reported but mainly from the western countries. We report the case of a young female Indian patient with AA unresponsive to therapy. Improvements in terms of hair regrowth were observed within 2 months of treatment with oral tofacitinib 5 mg BID tablets. The effectiveness of tofacitinib in hair regrowth was maintained till 5-month follow-up period. There were no side effects reported and the treatment with tofacitinib was well-tolerated.
How to cite this article:
Avhad G. Treatment of resistant alopecia areata with tofacitinib.Int J Trichol 2022;14:60-61
|
How to cite this URL:
Avhad G. Treatment of resistant alopecia areata with tofacitinib. Int J Trichol [serial online] 2022 [cited 2022 Jun 30 ];14:60-61
Available from: https://www.ijtrichology.com/article.asp?issn=0974-7753;year=2022;volume=14;issue=2;spage=60;epage=61;aulast=Avhad;type=0 |
|
